Quick Answer
OptimizeRx Corp reported Cash And Cash Equivalents At Carrying Value of $23.37 million for the year ending 2025.
- OptimizeRx Corp showed an increase of +74.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from OptimizeRx Corp's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $969.8 thousand | Q3 2011: $1.02 million | Q1 2012: $797.5 thousand | Q2 2012: $527.5 thousand | Q3 2012: $282.6 thousand | Q1 2013: $260.4 thousand | Q2 2013: $352.4 thousand | Q3 2013: $486.7 thousand | Q1 2014: $4.03 million | Q2 2014: $3.55 million | Q3 2014: $3.26 million | Q1 2015: $3.51 million | Q2 2015: $3.65 million | Q3 2015: $8.17 million | Q1 2016: $7.55 million | Q2 2016: $7.57 million | Q3 2016: $7.57 million | Q1 2017: $6.72 million | Q2 2017: $5.84 million | Q3 2017: $5.01 million | Q1 2018: $4.30 million | Q2 2018: $12.00 million | Q3 2018: $13.52 million | Q1 2019: $10.13 million | Q2 2019: $30.54 million | Q3 2019: $29.76 million | Q1 2020: $15.21 million | Q2 2020: $14.11 million | Q3 2020: $12.03 million | Q1 2021: $82.28 million | Q2 2021: $83.92 million | Q3 2021: $85.06 million | Q1 2022: $88.95 million | Q2 2022: $87.39 million | Q3 2022: $41.33 million | Q1 2023: $16.44 million | Q2 2023: $9.81 million | Q3 2024: $16.13 million | Q1 2025: $16.57 million | Q2 2025: $16.59 million | Q3 2025: $19.52 million.
- Over the full 16 years of available data (2010 to 2025), OptimizeRx Corp's Cash And Cash Equivalents At Carrying Value has grown by 1,728.1%.
- Historical annual values: Fiscal year 2025: $23.37 million | Fiscal year 2024: $13.38 million | Fiscal year 2023: $13.85 million | Fiscal year 2022: $18.21 million | Fiscal year 2021: $84.68 million | Fiscal year 2020: $10.52 million | Fiscal year 2019: $18.85 million | Fiscal year 2018: $8.91 million | Fiscal year 2017: $5.12 million | Fiscal year 2016: $7.03 million | Fiscal year 2015: $8.21 million | Fiscal year 2014: $3.45 million | Fiscal year 2013: $1.12 million | Fiscal year 2012: $284.3 thousand | Fiscal year 2011: $959.2 thousand | Fiscal year 2010: $1.28 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: